Efficacy of Bacopa Monnieri (Brahmi) and Donepezil in Alzheimer's Disease and Mild Cognitive Impairment: A Randomized Double-Blind Parallel Phase 2b Study

OBJECTIVES: Alzheimer's disease (AD) is the most common cause of dementia worldwide in the older population. There is no disease-modifying therapy available for AD. The current standard of care drug therapy for AD is cholinesterase inhibitors, including donepezil. Bacopa monnieri or brahmi is u...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Indian Acad Neurol
Main Authors: Prabhakar, Sudesh, Vishnu, Venugopalan Y., Modi, Manish, Mohanty, Manju, Sharma, Anchal, Medhi, Bikas, Mittal, BR, Khandelwal, Niranjan, Goyal, Manoj K., Lal, Vivek, Singla, Rajesh, Kansal, Avinash, Avasthi, Ajit
Formato: Artigo
Idioma:Inglês
Publicado em: Wolters Kluwer - Medknow 2020
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7900738/
https://ncbi.nlm.nih.gov/pubmed/33688125
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/aian.AIAN_610_19
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados